Literature DB >> 26833132

Impact of rotavirus vaccination on coverage and timing of pentavalent vaccination - Experience from 2 Latin American countries.

A Schweitzer1, F Pessler1,2, M K Akmatov1,2.   

Abstract

We examined the coverage and timing of rotavirus vaccination and the impact of rotavirus vaccine introduction on coverage and timing of the pentavalent vaccine. We used data from the Demographic and Health Surveys in Honduras (2011/2012) and Peru (2012). The samples were divided into 2 subcohorts: children born before and after the introduction of rotavirus vaccine. We compared coverage and timing of the pentavalent vaccine in the aforementioned subcohorts. Coverage with the first and second doses of rotavirus vaccination was 95% (95% confidence intervals: 93-97%) and 91% (89-95%) in Honduras and 79% (77-82%) and 72% (69-75%) in Peru, respectively. Coverage increased in both countries over the years. The proportion of children vaccinated according to age-appropriate vaccination schedules varied between 67% (second dose of rotavirus vaccinations in Peru) and 89% (first dose of rotavirus vaccination in Honduras). Coverage with the first and second doses of pentavalent vaccination remained constant over the years in Honduras, while in Peru there was a significant increase in coverage over the years (p for trend, <0.0001). In both countries, timing of pentavalent vaccination was better in post-rota-cohorts than in pre-rota-cohorts. Since its introduction, coverage of rotavirus vaccination has improved over time in both countries. An introduction of rotavirus vaccination in both countries appears to have improved the coverage and timing of other similarly scheduled vaccinations.

Entities:  

Keywords:  Honduras; Peru; pentavalent vaccination; rotavirus vaccination; timing; vaccination coverage

Mesh:

Substances:

Year:  2016        PMID: 26833132      PMCID: PMC4963056          DOI: 10.1080/21645515.2015.1127486

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  16 in total

1.  Progress in the introduction of the rotavirus vaccine in Latin America and the Caribbean: four years of accumulated experience.

Authors:  Lucia Helena de Oliveira; M Carolina Danovaro-Holliday; N Jennifer Sanwogou; Cuauhtemoc Ruiz-Matus; Gina Tambini; Jon Kim Andrus
Journal:  Pediatr Infect Dis J       Date:  2011-01       Impact factor: 2.129

2.  Rotavirus seasonal distribution and prevalence before and after the introduction of rotavirus vaccine in a peri-urban community of Lima, Peru.

Authors:  Millie R Chang; Grace Velapatiño; Miguel Campos; Elsa Chea-Woo; Nelly Baiocchi; Thomas G Cleary; Theresa J Ochoa
Journal:  Am J Trop Med Hyg       Date:  2015-03-16       Impact factor: 2.345

3.  Diarrhoea caused by rotavirus in a regional Peruvian hospital: determination of circulating genotypes.

Authors:  Pablo Weilg Espejo; Fiorella Orellana Peralta; Hernán Cornejo Pacheres; Luis J del Valle; Angela Cornejo Tapia; Jorge Bazán Mayra; Joaquim Ruiz; Juana Del Valle Mendoza
Journal:  Trans R Soc Trop Med Hyg       Date:  2014-04-27       Impact factor: 2.184

Review 4.  2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis.

Authors:  Jacqueline E Tate; Anthony H Burton; Cynthia Boschi-Pinto; A Duncan Steele; Jazmin Duque; Umesh D Parashar
Journal:  Lancet Infect Dis       Date:  2011-10-24       Impact factor: 25.071

5.  Progress in the introduction of rotavirus vaccine--Latin America and the Caribbean, 2006-2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-12-02       Impact factor: 17.586

6.  Invasive pneumococcal diseases among hospitalized children in Lima, Peru.

Authors:  Theresa J Ochoa; Martha Egoavil; María E Castillo; Isabel Reyes; Eduardo Chaparro; Wilda Silva; Francisco Campos; Andrés Sáenz
Journal:  Rev Panam Salud Publica       Date:  2010-08

7.  Impact of the introduction of rotavirus vaccine on the timeliness of other scheduled vaccines: the Australian experience.

Authors:  Brynley P Hull; Robert Menzies; Kristine Macartney; Peter B McIntyre
Journal:  Vaccine       Date:  2013-02-17       Impact factor: 3.641

8.  Uptake of oral rotavirus vaccine and timeliness of routine immunization in Brazil's National Immunization Program.

Authors:  Brendan Flannery; Samia Samad; José Cássio de Moraes; Jacqueline E Tate; M Carolina Danovaro-Holliday; Lúcia Helena de Oliveira; Jeanette J Rainey
Journal:  Vaccine       Date:  2013-01-10       Impact factor: 3.641

Review 9.  Rotavirus overview.

Authors:  David I Bernstein
Journal:  Pediatr Infect Dis J       Date:  2009-03       Impact factor: 2.129

10.  Global illness and deaths caused by rotavirus disease in children.

Authors:  Umesh D Parashar; Erik G Hummelman; Joseph S Bresee; Mark A Miller; Roger I Glass
Journal:  Emerg Infect Dis       Date:  2003-05       Impact factor: 6.883

View more
  4 in total

1.  Unintended pregnancy and its impact on childhood rotavirus immunization in Peru.

Authors:  Jose Echaiz; Magaly Blas; Vijaya Kancherla
Journal:  Rev Panam Salud Publica       Date:  2018-08-27

Review 2.  Characterization of immunization secondary analyses using demographic and health surveys (DHS) and multiple indicator cluster surveys (MICS), 2006-2018.

Authors:  Yue Huang; M Carolina Danovaro-Holliday
Journal:  BMC Public Health       Date:  2021-02-12       Impact factor: 3.295

Review 3.  Vaccination assessments using the Demographic and Health Survey, 2005-2018: a scoping review.

Authors:  Luke M Shenton; Abram L Wagner; Mengdi Ji; Bradley F Carlson; Matthew L Boulton
Journal:  BMJ Open       Date:  2020-12-02       Impact factor: 2.692

4.  Impact of Rotavirus Vaccination Varies by Level of Access to Piped Water and Sewerage: An Analysis of Childhood Clinic Visits for Diarrhea in Peru, 2005-2015.

Authors:  Miranda J Delahoy; César Cárcamo; Luis Ordoñez; Vanessa Vasquez; Benjamin Lopman; Thomas Clasen; Gustavo F Gonzales; Kyle Steenland; Karen Levy
Journal:  Pediatr Infect Dis J       Date:  2020-08       Impact factor: 3.806

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.